The World’s 1st Trial Testing Inhaled DMT Formulation
This week, a biotech research and development company on the NEO Exchange commenced dose administration of the first subject in a Phase I/IIa clinical trial of its novel drug candidate BMND01, for treatment-resistant depression with inhaled administration. A Stockhouse Editorial exclusive.Read the Full Story Here
Weekly Update - Top Cannabis News Stories
1 | Top Story: Filament Health Corp. announces fourth patent issuance.
2 | Delta 9 Cannabis Inc. obtains $5 million loan from shareholder.
3 | Cybin Inc. to participate in psychedelics virtual investor conference.
4 | NEO cannabis stock stakes two CBD acquisitions.
5 | Canopy Growth Corp. makes major announcement re: cost reduction actions.
Top Cannabis Stocks Apr 21 to Apr 27, 2022
1. T.HEXO | 20,402 views | HEXO Corp.
2. T.WEED |17,220 views | Canopy Growth Corp.
3. TLRY | 10,585 views | Tilray Brands Inc.
4. C.TNY | 10,161 views | Tinley Beverage Co Inc.
5. T.TBP | 4,678 views | Tetra Bio-Pharma Inc.
6. C.CHOO | 4,098 views | Choom Holdings Inc.
FULL DISCLOSURE: Filament Health Corp., Biomind Labs Inc., Delta 9 Cannabis Inc., and Cybin Inc. are clients of Stockhouse Publishing.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit Stockhouse’s new Cannabis Bullboards page.